Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance

Am J Hematol. 2017 Oct;92(10):E614-E618. doi: 10.1002/ajh.24861. Epub 2017 Jul 29.
No abstract available

Publication types

  • Letter
  • Periodical Index
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / blood
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / mortality
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / therapy
  • Male
  • Middle Aged
  • Mutation*
  • Nuclear Proteins* / genetics
  • Nuclear Proteins* / metabolism
  • Nucleophosmin
  • Retrospective Studies
  • Survival Rate

Substances

  • NPM1 protein, human
  • Nuclear Proteins
  • Nucleophosmin